Elicio Therapeutics, Inc.
🏢 View company profile →4Patents
4Active
4Granted
44Portfolio score
Filing activity: Jan 27, 2017 → Feb 28, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11623002B2 | ALK polypeptides and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US12370245B2 | ALK polypeptides and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12138301B2 | Compounds including a mutant KRAS sequence and a lipid and uses thereof | Human Necessities | 0 | Active |
| US12247052B2 | CpG amphiphiles and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.